Ovid Therapeutics, Inc. (OVID)
2.47
+0.07
(+2.92%)
USD |
NASDAQ |
Mar 26, 14:10
Ovid Therapeutics Cash from Investing (Quarterly) : -72.06M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 34.01M |
| CytomX Therapeutics, Inc. | -14.42M |
| Artelo Biosciences, Inc. | 0.1976M |
| Eton Pharmaceuticals, Inc. | -0.049M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.41M |
| Cash from Financing (Quarterly) | 75.18M |
| Free Cash Flow | -38.33M |
| Free Cash Flow Per Share (Quarterly) | -0.1274 |
| Free Cash Flow to Equity (Quarterly) | -10.06M |
| Free Cash Flow to Firm (Quarterly) | -10.41M |
| Free Cash Flow Yield | -21.05% |